Cardiovascular Risk Factor Burden in U.S. People With Incident Type 2 Diabetes Receiving Antidiabetic and Cardioprotective Therapies

Diabetes Care - United States
doi 10.2337/dc18-1865
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2011English

Cardiovascular Risk in Patients With Type 2 Diabetes

CMAJ
Medicine
2005English

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion
Medicine
2011English

Management of Cardiovascular Risk Factors With Pioglitazone Combination Therapies in Type 2 Diabetes: An Observational Cohort Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2011English

Leptin and Incident Type 2 Diabetes: Risk or Protection?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Epicardial Adipose Tissue Predicts Incident Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Type 2 Diabetes and the Risk of Incident Hearing Loss

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Antihypertensive Medications and the Risk of Incident Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Residual Cardiovascular Risk Among People With Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy